Articles

What a government shutdown could mean for you — and the odds it could happen

Optimism for avoiding a shutdown is on the rise — but the clock is ticking.

Tesla’s stock has lost its ‘Trump bump.’ Here’s the latest bad news.

Tesla’s stock is sinking after another month of bad China sales. Elon Musk has now lost about $7 billion in his stake since the election.

Why should I tip servers who earn $20 an hour?

“It seems the whole point of tipping was to make up for low wages, and that is no longer an issue.”

Trump’s first 50 days: Stocks heading toward worst start to a presidential term since 2009

The first 50 days of President Donald Trump’s second term have brought heightened volatility to financial markets already worried about slowing economic growth in the world’s largest economy.

Super Micro’s stock has its doubters, but it just got a vote of confidence

Super Micro is a “show-me story,” says a Rosenblatt analyst, but he sees room for gross margins to expand as the company sells more to enterprise customers.

LinkedIn co-founder has known Elon Musk for years. Here’s what he says Americans don’t understand about the Tesla CEO.

Elon Musk takes a hammer-and-nail approach to everything, LinkedIn co-founder Reid Hoffman says.

Do older adults understand healthcare risks?

Misperceptions of long-term care needs and costs are cause for concern

These 13 growth stocks have dropped this year. They are expected to roar back.

These companies are expected by analysts to increase revenue by at least double the rate of the S&P 500. Their stocks are expected to rise at least 29% over the next 12 months.

There’s a Fed put and a Trump put — but don’t forget the C-suite put as well

Companies may put a floor under stocks by switching to buybacks from capital expenditure, according to Citi strategists.

Nvidia’s stock is cheap by this metric. Can next week’s GTC get it going again?

Nvidia hosts its annual conference next week at a time when investors have soured on AI stocks.

Ozempic parent’s new weight-loss drug works better, but not quite good enough for analysts

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

HSBC double-upgrades Europe stocks as it lowers U.S. rating to neutral

The year has started with a big rally for European stocks as the U.S. market struggles to remain above water. Now, HSBC strategists are changing their tune.
1 119 120 121 122 123 2,079